Auxilium Pharmaceuticals, Inc. (AUXL) Tops Q3 EPS Views
Tweet
Share
E-mailGet Alerts AUXL Hot Sheet
Join SI Premium – FREE
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) reported Q3 EPS of ($0.08), $0.13 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $66.7 million versus the consensus estimate of $66.83 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
